Policy design of “Dual-channel” management for national negotiated drugs: A inter-provincial comparative analysis

Corresponding author: CUI Dan, cuidan@whu.edu.cn

DOI: 10.12201/bmr.202305.00006

•  

  Abstract: Objective: This study aims to compare and analyze the differences in the response time, connection mode with the original policy, and specific multidimensional content of the “dual-channel” management policies of National Medical Insurance Negotiation Drugs (NMIND) across various provinces, in order to find some references for optimizing the policy design in the future. Method: We utilized time trend analysis to characterize each province’s response time to national policies and performed text analysis using content analysis methodology to conduct multidimensional comparisons of the “dual-channel” management policies implemented in each province. Result: The designs of “dual-channel” management policies of NMIND in various provinces exhibit noticeable obvious differences in certain aspects, such as policy germination and response time, the connection mode with the original policy, criteria for selecting medical institutions and pharmacies, reduction of restrictive factors, and level of reimbursement. Conclusion: In the future, certain provinces should focus on improving the design of their “dual-channel” management policies by optimizing policy convergence, clarifying selection criteria, reducing unfavorable factors, and narrowing reimbursement gaps. These measures will help to promote the supply level of NMIND.

  Key words: “Dual-channel” management; National medical insurance negotiation drugs (NMIND); Policy design; Comparative research

  Submit time: 10 May 2023

  Copyright: The copyright holder for this preprint is the author/funder, who has granted biomedRxiv a license to display the preprint in perpetuity.
• html

• 图表

• MENG wen-xin, JIANG Rong. Comparison study of dual channel management policies of nationally negotiated drugs in Jiangsu province. 2022. doi: 10.12201/bmr.202209.00002

  ZhangJinsui, Humin, ChenWen, GongYichun, LI Jian-mei. Exploration and enlightenment of the content design of credit management for the basic medical insurance participants in China——Based on the content analysis of the text of credit management policy of 18 regions. 2022. doi: 10.12201/bmr.202207.00025

  JiangMingzhu, Ying Xiaohua. Quantitative research of vaccine management policy in China - Text analysis based on policy instruments, policy subjects and policy points. 2022. doi: 10.12201/bmr.202212.00005

  LYU Lan-ting. Research on the evolution and diffusion mechanism of drug negotiation policy in China*. 2022. doi: 10.12201/bmr.202210.00019

  Li Xinyu, Shao Rong, Bai Mingyu, Li Dashuang, Yan Jianzhou. Text Quantitative Analysis of Pediatric Drug Security policy-- A two-dimensional framework based on policy tools and policy goals. 2022. doi: 10.12201/bmr.202209.00016

  Rong Hongguo, XING Ye-yiyi, dong yue, xia ruyu, SHANG Hong-cai, Liu jianping, FEI Yu-tong. Analysis of rational use of antibacterial drugs policies based on the perspective of policy tools. 2021. doi: 10.12201/bmr.202107.00021

  DingTao, LiuFeng, YangSai. Comparative Study on Application of Integration Technology of Medical Big Data Dual Active System. 2023. doi: 10.12201/bmr.202303.00015

  ZHANG FENG. Design and Research of Intelligent Laboratory Management System. 2021. doi: 10.12201/bmr.202109.00027

  gaodi, WeiQipeng. The inter-institution scientific research management information System Design and practice. 2023. doi: 10.12201/bmr.202301.00001

  YAN Jian-zhou, LI Da-shuang, Ding Wenjing, SHAO Rong. Comparative study of promoted generic substitution policies in China, USA and Japan based on full cycle management. 2023. doi: 10.12201/bmr.202305.00004

• ID	Submit time	Number	Download
  1	2023-01-03	bmr.202305.00006V1	Download

• Public  Anonymous  To author only Submit Comments